Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2026-02-02 @ 5:04 PM
Study NCT ID:
NCT03813394
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-11-22
First Post:
2019-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPC
Sponsor:
Organization: